XML 24 R10.htm IDEA: XBRL DOCUMENT v3.26.3
STOCK-BASED COMPENSATION
9 Months Ended
Sep. 30, 2026
STOCK-BASED COMPENSATION  
STOCK-BASED COMPENSATION

4. STOCKHOLDERS’ EQUITY

STOCK-BASED COMPENSATION

Pursuant to the Company’s 2018 Omnibus Equity Incentive Plan (as amended, the “Incentive Plan”), the Company grants stock options, restricted stock units, performance-based restricted stock units (“PSUs”) and restricted stock to the Company’s employees, officers, directors, and other eligible participants. As of September 30, 2026, 2,153,202 shares of common stock remained available for issuance under the Incentive Plan.

Total stock-based compensation expense was $1.6 million and $1.4 million for the thirteen weeks ended September 30, 2026, and September 24, 2025, respectively, and $4.5 million and $4.1 million for the thirty-nine weeks ended September 30, 2026, and September 24, 2025, respectively.

Stock Options

As of September 30, 2026, options to purchase 1,289,657 shares of common stock were outstanding, including 439,386 vested and 850,271 unvested options. Unvested options vest over time; however, pursuant to the Incentive Plan, upon a change in control, the Company’s Board of Directors (the “Board”) may accelerate vesting. A summary of stock option activity at September 30, 2026, and changes during the thirty-nine weeks ended September 30, 2026, is as follows:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted-Average

 

Aggregate

​

  ​ ​ ​

​

  ​ ​ ​

Weighted-Average

 

 Contractual Life

 

Intrinsic Value

​

​

Shares

​

Exercise Price

 

Life (Years)

 

(in thousands)

Outstanding – December 31, 2025

 

1,233,984

​

$

10.46

​

​

​

​

​

​

Grants

 

398,209

​

 

13.40

​

​

​

​

​

​

Exercised

 

(256,181)

​

​

10.73

​

​

​

​

​

​

Forfeited, cancelled or expired

 

(86,355)

​

​

11.74

​

​

​

​

​

​

Outstanding – September 30, 2026

 

1,289,657

​

$

11.23

​

​

8.19

​

$

4,192

Vested and expected to vest at September 30, 2026

 

1,279,259

​

$

11.23

​

​

8.18

​

$

4,166

Exercisable at September 30, 2026

 

439,386

​

$

10.37

​

​

7.22

​

$

1,834

​

The fair value of each stock option was estimated on the grant date using an exercise price of the closing stock price on the day prior to date of grant and the Black-Scholes option-pricing model with the following weighted average assumptions:

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

Thirty-Nine Weeks Ended

 

​

​

September 30, 2026

​

September 24, 2025

​

Expected volatility

​

​

41.2

%  

​

42.8

%

Risk-free interest rate

 

​

3.9

%  

​

4.1

%

Expected term (years)

 

​

6.00

 

​

6.00

​

Expected dividends

 

$

—

 

$

—

​

​

At September 30, 2026, the Company had total unrecognized compensation expense of $3.7 million related to unvested stock options, which it expects to recognize over a weighted-average period of 2.03 years.

Restricted Shares

A summary of restricted share activity as of September 30, 2026 and changes during the thirty-nine weeks ended September 30, 2026 is as follows:

​

​

​

​

​

​

​

​

  ​ ​ ​

​

  ​ ​ ​

Weighted-Average

​

​

Shares

​

Fair Value

Unvested shares at December 31, 2025

 

617,037

​

$

10.22

Granted

 

346,844

​

$

13.41

Released

 

(263,005)

​

$

10.22

Forfeited and cancelled

 

(43,180)

​

$

11.28

Unvested shares at September 30, 2026

 

657,696

​

$

11.83

​

At September 30, 2026, the Company had unrecognized compensation expense of $6.0 million related to unvested restricted shares, which it expects to recognize over a weighted-average period of 1.97 years.

​

​

​

​

Performance-Based Restricted Stock Units

A summary of performance share activity as of September 30, 2026 and changes during the thirty-nine weeks ended September 30, 2026 is as follows:

​

​

​

​

​

​

​

​

  ​ ​ ​

​

  ​ ​ ​

Weighted-Average

​

​

Shares

​

Fair Value

Unvested shares at December 31, 2025

 

137,805

​

$

10.34

Granted

​

153,900

​

$

13.48

Released

​

—

​

$

—

Forfeited and cancelled

​

(34,002)

​

$

11.27

Unvested shares at September 30, 2026

​

257,703

​

$

12.09

​

​

​

​

​

​

At September 30, 2026, the Company had unrecognized compensation expense of $2.2 million related to unvested performance-based restricted shares, which it expects to recognize over a weighted-average period of 2.19 years.

SHARE REPURCHASE PROGRAM

On May 28, 2026, the Board of Directors approved a share repurchase program (the “2026 Share Repurchase Program”) under which the Company is authorized to repurchase up to $40.0 million of shares of its common stock. Under the 2026 Share Repurchase Program, the Company is permitted to repurchase its common stock from time to time, in amounts and at prices that the Company deems appropriate, based on various factors, including the market price of its common stock, general business, economic and market conditions, alternative investment opportunities and funding considerations. Pursuant to the 2026 Share Repurchase Program, the Company is authorized to effect repurchases through open market purchases, block trades, privately negotiated transactions or other transactions conducted in accordance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended, including pursuant to Rule 10b5-1 trading plans. The 2026 Share Repurchase Program does not obligate the Company to acquire any particular number of shares, has an open-ended term and may be expanded, modified, suspended or discontinued at any time.

For the thirteen and thirty-nine weeks ended September 30, 2026, the Company repurchased 177,410 shares of common stock under the 2026 Share Repurchase Program, using open market purchases, for total consideration of $2.7 million.

The Company did not repurchase any shares of common stock during the thirteen weeks ended September 24, 2025. For the thirty-nine weeks ended September 24, 2025, the Company repurchased 163,229 shares of common stock under the 2023 Share Repurchase Program, using open market purchases, for total consideration of $1.8 million.